X-48898423-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The ENST00000218224.9(PQBP1):c.-87C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00279 in 982,613 control chromosomes in the GnomAD database, including 5 homozygotes. There are 747 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0022 ( 0 hom., 71 hem., cov: 22)
Exomes 𝑓: 0.0029 ( 5 hom. 676 hem. )
Consequence
PQBP1
ENST00000218224.9 5_prime_UTR
ENST00000218224.9 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.49
Genes affected
PQBP1 (HGNC:9330): (polyglutamine binding protein 1) This gene encodes a nuclear polyglutamine-binding protein that is involved with transcription activation. The encoded protein contains a WW domain. Mutations in this gene have been found in patients with Renpenning syndrome 1 and other syndromes with X-linked cognitive disability. Multiple alternatively spliced transcript variants that encode different protein isoforms have been described for this gene.[provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant X-48898423-C-T is Benign according to our data. Variant chrX-48898423-C-T is described in ClinVar as [Benign]. Clinvar id is 368452.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00218 (243/111701) while in subpopulation AMR AF= 0.00333 (35/10498). AF 95% confidence interval is 0.00246. There are 0 homozygotes in gnomad4. There are 71 alleles in male gnomad4 subpopulation. Median coverage is 22. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 71 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PQBP1 | NM_001032382.2 | c.-18-69C>T | intron_variant | ENST00000447146.7 | NP_001027554.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PQBP1 | ENST00000447146.7 | c.-18-69C>T | intron_variant | 1 | NM_001032382.2 | ENSP00000391759 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00217 AC: 242AN: 111648Hom.: 0 Cov.: 22 AF XY: 0.00210 AC XY: 71AN XY: 33830
GnomAD3 genomes
AF:
AC:
242
AN:
111648
Hom.:
Cov.:
22
AF XY:
AC XY:
71
AN XY:
33830
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00287 AC: 2499AN: 870912Hom.: 5 Cov.: 15 AF XY: 0.00277 AC XY: 676AN XY: 243750
GnomAD4 exome
AF:
AC:
2499
AN:
870912
Hom.:
Cov.:
15
AF XY:
AC XY:
676
AN XY:
243750
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00218 AC: 243AN: 111701Hom.: 0 Cov.: 22 AF XY: 0.00209 AC XY: 71AN XY: 33893
GnomAD4 genome
AF:
AC:
243
AN:
111701
Hom.:
Cov.:
22
AF XY:
AC XY:
71
AN XY:
33893
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Renpenning syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at